£

Shaline's Story

For Shaline, every moment with her family became even more precious after she was diagnosed with multiple myeloma, which can be one of the deadliest blood cancers. As a mum of two, she knows how much it means to have more time with the people you love.

Thanks to research and clinical trials, Shaline has been able to access treatment that has given her hope for the future. But for many people facing the deadliest blood cancers, time is running out.

This Christmas, your gift could help launch vital new trials, find life-changing treatments and help more families face the future with hope instead of fear.

Shaline and her daughter

Help more people like Shaline

  • could help someone like Shaline share their experience, helping researchers design studies that put patients and families first.
  • could help people living with blood cancer shape the treatments of tomorrow.
  • could help more people affected by blood cancer take part in clinical trials with confidence.
Donate

Today, only one in three people survive the deadliest blood cancers.

While there has been huge progress in treatments for some forms of blood cancer, others have been left behind. Today, only one in three people with the deadliest forms of leukaemia, lymphoma and myeloma survive. We're determined to change that.

Blood Cancer UK's £25 million plan, Trial Treat Beat, aims to double survival chances by funding innovative clinical trials that can test multiple treatments at the same time.

If a treatment isn't working, researchers can quickly replace it with a more promising option. That means faster progress towards better, more personalised treatments for people facing the deadliest blood cancers.

Rubina

“Thanks to a new type of clinical trial, we’re more determined than ever.”

Dr Rubina Ahmed - Director of Research, Policy and Services, Blood Cancer UK

Please give today to help Trial Treat Beat save more lives.

Traditional clinical trials test one treatment at a time. If it doesn't work, researchers have to start again.

Trial Treat Beat will fund three innovative clinical trials that can test multiple treatments at the same time. This means promising new treatments can be identified faster and made available to people living with the deadliest blood cancers sooner.

New treatments are so close

If a treatment isn’t working, researchers drop it and add a new one. When promising therapies emerge, they then test them immediately.

This means that we can develop personalised treatments at a much faster pace for the deadliest blood cancers.

Your support today can help accelerate more treatments for people like Shaline.

Donate today